A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
Sponsor and Collaborators
Novartis Pharmaceuticals
Contact
Novartis Pharmaceuticals
+1(800)340-6843
Investigator
Novartis Pharmaceuticals
Continue Reading
ClinicalTrials.gov Identifier
NCT01473901